Eastwood Bio-Medical Canada Inc. (EWOOF)
USD 0.69
(N/A%)
USD 0.69
(N/A%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -364.61 Thousand CAD | -255.53% |
| 2022 | -102.55 Thousand USD | 79.51% |
| 2021 | -500.57 Thousand USD | 32.16% |
| 2020 | -737.92 Thousand USD | -68.02% |
| 2019 | -439.17 Thousand USD | -130.22% |
| 2018 | -190.76 Thousand CAD | 67.57% |
| 2017 | -588.27 Thousand CAD | -17.31% |
| 2016 | -501.46 Thousand CAD | -73.89% |
| 2015 | -288.38 Thousand CAD | 44.45% |
| 2014 | -519.16 Thousand CAD | -261.47% |
| 2013 | -143.62 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -139.93 Thousand CAD | -108.9% |
| 2024 Q3 | -90.55 Thousand CAD | 24.38% |
| 2024 Q1 | -73.17 Thousand CAD | 57.63% |
| 2023 Q3 | -87.24 Thousand USD | 31.4% |
| 2023 Q4 | -109.47 Thousand CAD | -25.49% |
| 2023 FY | -364.61 Thousand CAD | -255.53% |
| 2023 Q1 | -50.03 Thousand USD | -272.83% |
| 2023 Q2 | -127.17 Thousand USD | -154.15% |
| 2022 Q4 | -13.42 Thousand USD | -41.24% |
| 2022 Q3 | -9502.00 CAD | 91.91% |
| 2022 Q2 | -117.44 Thousand CAD | -2458.78% |
| 2022 Q1 | -4590.00 CAD | 72.11% |
| 2022 FY | -102.55 Thousand USD | 79.51% |
| 2021 Q1 | -156.82 Thousand CAD | 49.31% |
| 2021 Q3 | -175.22 Thousand CAD | 23.16% |
| 2021 Q4 | -16.46 Thousand CAD | 90.61% |
| 2021 FY | -500.57 Thousand USD | 32.16% |
| 2021 Q2 | -228.02 Thousand CAD | -45.39% |
| 2020 FY | -737.92 Thousand USD | -68.02% |
| 2020 Q1 | -184.22 Thousand CAD | -34.02% |
| 2020 Q3 | -54.52 Thousand CAD | 69.05% |
| 2020 Q4 | -309.41 Thousand CAD | -467.44% |
| 2020 Q2 | -176.17 Thousand CAD | 4.37% |
| 2019 Q2 | -178.3 Thousand CAD | -3558.09% |
| 2019 Q3 | -66.33 Thousand CAD | 62.79% |
| 2019 Q4 | -137.45 Thousand CAD | -107.2% |
| 2019 FY | -439.17 Thousand USD | -130.22% |
| 2019 Q1 | -4874.19 CAD | -135.88% |
| 2018 Q3 | -125.09 Thousand CAD | 29.56% |
| 2018 Q2 | -177.58 Thousand CAD | -24.84% |
| 2018 Q1 | -142.25 Thousand CAD | -10.75% |
| 2018 FY | -190.76 Thousand CAD | 67.57% |
| 2018 Q4 | 13.58 Thousand CAD | 110.86% |
| 2017 FY | -588.27 Thousand CAD | -17.31% |
| 2017 Q4 | -128.44 Thousand CAD | -12.44% |
| 2017 Q2 | -90.03 Thousand CAD | 16.43% |
| 2017 Q1 | -107.74 Thousand CAD | -6.56% |
| 2017 Q3 | -114.24 Thousand CAD | -26.88% |
| 2016 Q2 | -92.04 Thousand CAD | -39.08% |
| 2016 Q3 | -112.93 Thousand CAD | -22.7% |
| 2016 Q1 | -66.18 Thousand CAD | -75.97% |
| 2016 FY | -501.46 Thousand CAD | -73.89% |
| 2016 Q4 | -101.1 Thousand CAD | 10.48% |
| 2015 Q4 | -37.6 Thousand CAD | -27.33% |
| 2015 Q2 | -336.91 CAD | 99.75% |
| 2015 FY | -288.38 Thousand CAD | 44.45% |
| 2015 Q1 | -135.92 Thousand CAD | 9.08% |
| 2015 Q3 | -29.53 Thousand CAD | -8667.04% |
| 2014 Q2 | -57.4 Thousand CAD | -52.83% |
| 2014 Q1 | -37.56 Thousand CAD | 58.35% |
| 2014 FY | -519.16 Thousand CAD | -261.47% |
| 2014 Q3 | -102.92 Thousand CAD | -79.28% |
| 2014 Q4 | -149.5 Thousand CAD | -45.27% |
| 2013 Q3 | -50.51 Thousand CAD | -45.87% |
| 2013 Q2 | -34.63 Thousand CAD | 0.0% |
| 2013 Q4 | -90.19 Thousand CAD | -78.56% |
| 2013 FY | -143.62 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AiXin Life International, Inc. | -2.49 Million USD | 85.409% |
| Energroup Holdings Corp. | 25.49 Million USD | 101.43% |
| Green PolkaDot Box Incorporated | - USD | Infinity% |
| Innovative Food Holdings, Inc. | -3.25 Million USD | 88.794% |
| Medicale Corp | -37.59 Thousand USD | -869.891% |
| Nascent Wine Company, Inc. | 5.49 Million USD | 106.636% |
| Natural Harmony Foods, Inc. | - USD | Infinity% |
| NXT Nutritionals Holdings, Inc. | -4.44 Million USD | 91.804% |
| Pacific Ventures Group, Inc. | -3.24 Million USD | 88.751% |
| Verus International, Inc. | - USD | Infinity% |
| Wanderport Corporation | -9787.00 USD | -3625.462% |